These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9555092)

  • 1. Pristanic acid beta-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
    Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
    Biochim Biophys Acta; 1998 Apr; 1391(3):351-6. PubMed ID: 9555092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of pristanic acid beta-oxidation intermediates in plasma from healthy controls and patients affected with peroxisomal disorders by stable isotope dilution gas chromatography mass spectrometry.
    Verhoeven NM; Schor DS; Struys EA; Jansen EE; ten Brink HJ ; Wanders RJ; Jakobs C
    J Lipid Res; 1999 Feb; 40(2):260-6. PubMed ID: 9925655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
    Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
    Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
    Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
    J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
    Paton BC; Sharp PC; Crane DI; Poulos A
    J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical findings in a series of Australian patients with isolated defects in peroxisomal beta-oxidation.
    Paton BC; Sharp PC; Poulos A
    Ann N Y Acad Sci; 1996 Dec; 804():750-1. PubMed ID: 8993614
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic heterogeneity in patients with a disorder of peroxisomal beta-oxidation: a complementation study based on pristanic acid beta-oxidation suggesting different enzyme defects.
    van Grunsven EG; Wanders RJ
    J Inherit Metab Dis; 1997 Jul; 20(3):437-40. PubMed ID: 9266375
    [No Abstract]   [Full Text] [Related]  

  • 8. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
    Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
    Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
    J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts.
    Wanders RJ; Denis S; Ruiter JP; Schutgens RB; van Roermund CW; Jacobs BS
    J Inherit Metab Dis; 1995; 18 Suppl 1():113-24. PubMed ID: 9053546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the newly discovered 58 kDa peroxisomal thiolase SCPx as the main thiolase involved in both pristanic acid and trihydroxycholestanoic acid oxidation: implications for peroxisomal beta-oxidation disorders.
    Wanders RJ; Denis S; van Berkel E; Wouters F; Wirtz KW; Seedorf U
    J Inherit Metab Dis; 1998 Jun; 21(3):302-5. PubMed ID: 9686381
    [No Abstract]   [Full Text] [Related]  

  • 12. Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts.
    Verhoeven NM; Roe DS; Kok RM; Wanders RJ; Jakobs C; Roe CR
    J Lipid Res; 1998 Jan; 39(1):66-74. PubMed ID: 9469587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency.
    Van Veldhoven PP; Meyhi E; Squires RH; Fransen M; Fournier B; Brys V; Bennett MJ; Mannaerts GP
    Eur J Clin Invest; 2001 Aug; 31(8):714-22. PubMed ID: 11473573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisomal bifunctional enzyme deficiency.
    Watkins PA; Chen WW; Harris CJ; Hoefler G; Hoefler S; Blake DC; Balfe A; Kelley RI; Moser AB; Beard ME
    J Clin Invest; 1989 Mar; 83(3):771-7. PubMed ID: 2921319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific method for determination of peroxisomal beta-oxidation activity in cultured human skin fibroblasts using a specific substrate, C9: a possible application for screening of peroxisomal disorders.
    Suzuki H; Yamada J; Watanabe T; Suga T
    Clin Chim Acta; 1992 Apr; 207(1-2):19-29. PubMed ID: 1591864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-hydroxyacyl-CoA dehydrogenase deficiency. Identification of a new peroxisomal disorder with implications for other disorders of beta-oxidation.
    van Grunsven EG; van Berkel E; Denis S; Mooijer PA; Wanders RJ
    Adv Exp Med Biol; 1999; 466():365-9. PubMed ID: 10709664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids.
    Christensen E; Pedersen SA; Leth H; Jakobs C; Schutgens RB; Wanders RJ
    J Inherit Metab Dis; 1997 Sep; 20(5):658-64. PubMed ID: 9323560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactic acidosis in long-chain fatty acid beta-oxidation disorders.
    Ventura FV; Ruiter JP; IJlst L; de Almeida IT; Wanders RJ
    J Inherit Metab Dis; 1998 Aug; 21(6):645-54. PubMed ID: 9762600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
    Kase BF; Björkhem I
    Scand J Clin Lab Invest; 1996 May; 56(3):211-7. PubMed ID: 8761525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that multifunctional protein 2, and not multifunctional protein 1, is involved in the peroxisomal beta-oxidation of pristanic acid.
    Dieuaide-Noubhani M; Asselberghs S; Mannaerts GP; Van Veldhoven PP
    Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):367-73. PubMed ID: 9230115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.